Psoriasis is a chronic inflammatory skin disease that is prone to relapse. This experiment applied
META HUNTER to treat 18 cases of psoriasis vulgaris and conducted a randomized controlled observation with general conventional treatment. The report is as follows.
1 Materials and methods
1.1 General information: There are 36 cases in this group, who were outpatients in our hospital from July 2005 to June 2006. Diagnosis: psoriasis vulgaris. 36 cases were divided into two groups according to the numerical random method, with 18 cases in each group. Among the 18 cases in the treatment group, there were 7 males and 11 females; the age range was 8 to 70 years old, with an average age of 36 years; the disease duration ranged from 2 months to 15 years. Among the 18 cases in the control group, 8 were male and 10 were female; their age ranged from 10 to 68 years old, with an average of 38 years old; and the disease duration ranged from 3 months to 12 years. There was no significant difference in gender, age, and course of disease between the two groups after statistical processing (P>0.05).
1.2 Treatment methods: The control group was given oral vitamin C, vitamin B complex, Torch Flower Root Tablets, etc., and topical halometasone ointment, anti-inflammatory ringworm ointment (Bebao), 10% urea ointment, etc. The treatment group used
META HUNTER on the basis of the treatment in the control group. Allergens were first detected, and then basic treatment, scar elimination, environment adjustment, detoxification, immunity regulation, and allergen removal were performed (common allergens in all patients were pepper, wheat, milk, fish, etc.). Treatment is given once a week for a total of 5 to 10 times.
1.3 Efficacy standard: The improvement of rash 2 months after the end of treatment and the recurrence after 1 year are used as clinical efficacy evaluation standards. Recovery means that all skin lesions have subsided, with no recurrence after 1 year; effective means that the skin lesions have subsided by ≥80%, and there are still skin lesions (440%) after 1 year; ineffective means that the skin lesions have subsided by ≤25% or the skin lesions have subsided.
Post-recurrence >160%.
2 results
2.1 Efficacy: There is a significant difference in the total effective rate between the two groups (both P<0.05).
2.2 Adverse reactions: 10 cases in the treatment group developed pruritus, which improved without treatment and did not affect the treatment. No other adverse reactions occurred in the two groups of patients.
3 Discussion
Psoriasis is a chronic inflammatory skin disease that is prone to relapse. This disease is controlled by multiple genes and is also affected by many factors such as internal and external environment. The onset is related to heredity, infection, and immunity.
META HUNTER treats psoriasis mainly by collecting abnormal information from the human body, detecting allergens, inverting and amplifying abnormal biological resonance waves and injecting them into the patient's body, while also inputting corresponding anti-inflammatory, immune support and other programs to regulate the human body. Environment; avoid allergens and perform deallergic treatment so that the patient's internal and external environment can be improved to achieve the purpose of treatment. We believe that this device, as a new auxiliary method for the treatment of psoriasis, has good clinical efficacy and basically no side effects (it is prohibited for pregnant women and organ transplant patients).